IP Library Granted Patent US 7,674,813
Granted Patent B2
US 7,674,813 · App. 12/142,306 · Granted Mar 9, 2010

Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole

Assignee: Wyeth
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,813
App. No.
12/142,306
Granted
Mar 9, 2010
Kind
B2
Abstract

Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R 1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO 2 R 5 ; R 5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R 2 is lower alkyl, substituted lower alkyl, CF 3 , alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R 3 is hydrogen, lower alkyl, or substituted lower alkyl; R 4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R 6 is hydrogen, lower alkyl, substituted lower alkyl, CF 3 , alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR 7 or N; and R 7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.

Claims (21)

1. A compound of formula (Ia) or a pharmaceutically acceptable salt thereof, of the structure:

wherein:

R 1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO 2 R 5 ;

R 5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;

R 2 is selected from the group consisting of lower alkyl, substituted lower alkyl, CF 3 , alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, and cycloalkyl;

R 3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;

R 4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, and substituted thiophene;

R 6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF 3 , alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;

W, X, and Y are selected from the group consisting of (i), (ii), and (iii):

(i) W is N, Y is CR 7 , and X is N;

(ii) W is CR 7 , Y is CR 7 , and X is N; and

(iii) W is CR 7 , Y is CR 7 , and X is CR 7 ;

R 7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl.

2. The compound according to claim 1 , wherein R 1 is substituted benzyl.

3. The compound according to claim 1 , wherein R 1 is substituted phenyl.

4. The compound according to claim 1 , wherein R 2 is lower alkyl.

5. The compound according to claim 2 , wherein R 3 is hydrogen.

6. The compound according to claim 2 , wherein R 4 is thiophene or substituted thiophene.

7. The compound according to claim 6 , wherein R 4 is 5-chloro-2-thiophene.

8. The compound according to claim 1 , wherein R 6 is H.

9. The compound according to claim 1 which is 5-Chloro-N-{2-ethyl-1-[1-(4-fluorobenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide, 5-Chloro-N-(2-ethyl-1-{1-[4-(trifluoromethoxy)benzyl]-1H-1,2,4-triazol-5-yl}butyl)thiophene-2-sulfonamide, 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide, N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide, N-[1-(1-Benzyl-1H-1,2,4-triazol5-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide, 5-Chloro-N-{2-methyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]propyl}thiophene-2-sulfonamide, N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)ethyl]-5-chlorothiophene-2-sulfonamide, 5-Chloro-N-{1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]ethyl}thiophene-2-sulfonamide, 5-Chloro-N-{2-ethyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide, N-[1-(1-Benzyl-1H-imidazol-2-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide, 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1 H-imidazol-2-yl]butyl}thiophene-2-sulfonamide, 5-Chloro-N-{2-ethyl-1-[1-(4-hydroxybenzyl)-1-H-imidazol-2-yl]butyl}thiophene-2-sulfonamide, and N-[1-(1-Benzyl-1H-pyrrol-2-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide.

Assignments (1)
CHANGE OF NAME Recorded Jan 11, 2011
From: WYETH
To: WYETH LLC
Reel/Frame 025615/0874 →
Continuity (3)
Division 1103500500 · Jan 13, 2005
Provisional Application 6053708600 · Jan 16, 2004
Related Publication 20080249150A1 · Oct 9, 2008